-+ 0.00%
-+ 0.00%
-+ 0.00%

Millrose Properties (MRP) Stock Ignores Q3 Earnings Cash Flow Strength

Simply Wall St·10/28/2026 02:19:21
Listen to the news

Millrose Properties just dropped Q3 2026 numbers and the stock barely flinched, up 1.7% to US$24.31 after the release. For a real estate investment trust, that is a muted response to what appear to be fairly muscular fundamentals. Adjusted funds from operations, or AFFO, for the quarter landed around US$133.5m, roughly US$0.80 per share, against a book value near US$35 per share. The main point is that the market is treating this as a routine quarter, while the earnings print highlights a story focused on cash flow strength and a wide gap between price and underlying equity value.

Love Millrose Properties' hefty cash generation but uneasy about paying up for a REIT with a wide gap between share price and book value? Compare that setup with a curated group of stocks that have similar cash flow support and stronger balance sheets in our list of solid balance sheet and fundamentals stocks (24 results)

Q3 2026 Earnings Summary

  • Total Revenue (Q3 2026 vs Q3 2025): US$211.0m vs. US$179.3m (up about 18%)
  • Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025): US$130.0m vs. US$105.1m (up about 24%)
  • Basic EPS (Q3 2026 vs Q3 2025): US$0.78 vs. US$0.63 (up about 24%)
  • Funds From Operations (FFO, Q3 2026 vs Q3 2025): US$130.0m vs. US$105.1m (up about 24%)

Millrose just tied a new capital plan to its cheap stock. Ask Charlie what Millrose will really do with buybacks.

NYSE:MRP Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
NYSE:MRP Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Millrose bullish story: builder engine delivers, tech proof pending

The upbeat view hangs on deeper builder programs steadily lifting recurring economics rather than one off deals.

"Expanding national relationships with 12 homebuilder counterparties and growing penetration of existing programs, such as the Yardly build to rent partnership, position Millrose to steadily increase option fee income and total revenue as more communities are brought under its model."

Millrose Properties now reports 22 builder and developer counterparties, 834 communities and recurring option fee income of about US$209.5m in Q3. That expansion and the raised AFFO guidance support the idea that the platform is gaining traction. The claim that AI and data tools will cut credit losses is still more promise than measurable outcome in this print.

Millrose bear case: housing cycle, leverage and legal risk

The sceptical view focuses on cycle exposure, balance sheet stretch and now legal scrutiny around Lennar transactions.

"Millrose's growth is tied to sustained high housing production. A prolonged downturn in homebuilding caused by weaker demand or tighter mortgage affordability could slow homesite takedowns and new transaction funding, reducing option fee income and overall revenue growth."

Q3 shows solid option fee receipts and no customer terminations, which pushes against fears of an immediate takedown freeze. Yet the BTR pilot involves roughly US$333m of homes and reported rent pressure, while debt to capital sits near 36% and moves closer to 40% pro forma Dream Finders. Class actions around Lennar disclosures add another overhang even as management leans on unsecured notes to keep funding intact.

One Narrative disagrees with today's price. → See where this Narrative says Millrose Properties should trade.

Hunt For Quiet Cash Engines

Millrose Properties just showed how a solid quarter can still leave a muted share reaction. The real opportunity could be spotting stocks that look mispriced before the crowd fully catches on.

  • Company 1 - 42% below our estimate - uses a growing backlog of tracker, software and storage deals to deepen ties with large project developers.
  • Company 2 - 31% below our estimate - converts complex aerospace, defense and healthcare design wins into long-lived manufacturing programs that embed it in regulated customers' supply chains.
  • Company 3 - 23% below our estimate - expands robotic surgery platforms into new joint procedures and layered service offerings that can increase usage at existing hospital customers.

Those are three of them. See the full list of 29 companies trading below our fair value estimates →